PDCD1 and melanoma: For an independent dataset regarding melanoma samples treated with anti‐PD1 (Liu cohort),45 the mutation group showed an improved OS relative to the WT group (Figure 5C, log‐rank p = 0.061; HRsingle vs. WT = 0.277, 95% CI = 0.087–0.887, p = 0.031).